Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Wacker Chemie AG (WCH.DE)
Munich, DE
Wacker Chemie AG is a global enterprise delivering a diverse portfolio of chemical products through its worldwide operations. The company's business is structured across four principal divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones segment produces an extensive array of silicone-based items, including silanes, siloxanes, fluids, emulsions, elastomers, resins, and pyrogenic silicas, which are essential for industries such as construction, electronics, automotive, healthcare, and renewable energy. Meanwhile, Wacker Polymers specializes in the provision of binders and polymeric additives, notably dispersible polymer powders and vinyl acetate-ethylene dispersions, crucial for applications in construction, paper manufacturing, adhesives, paints, coatings, and fundamental chemical processes. Wacker Biosolutions focuses on bespoke biotechnological solutions and a specialized catalog of fine chemicals. Its offerings, encompassing pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone, serve as key components for pharmaceutical active ingredients, food additives, and agricultural chemicals. Finally, the Wacker Polysilicon unit is dedicated to manufacturing hyperpure polysilicon, an indispensable material for both the semiconductor and solar energy sectors. Tracing its origins back to 1914, Wacker Chemie AG maintains its headquarters in Munich, Germany, and functions as a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.26% | +2.50% | +5.81% | +19.50% | +51.37% | +35.72% | +46.88% | -31.44% | -23.26% | +20.01% | -1.03% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | -2 |
| Hold | 9 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-4.1% Q1'26: -4.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-440.8% Q1'26: +231.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-6.8% Q1'26: +5.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-1.9% Q1'26: +3.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-2.3% Q1'26: +5.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +47.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×5.97× Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 9 Rev. Ana. 9 EPS Ana. |
Dec 2027 13 Rev. Ana. 9 EPS Ana. |
Dec 2028 8 Rev. Ana. 6 EPS Ana. |
Dec 2029 7 Rev. Ana. 4 EPS Ana. |
Dec 2030 7 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.91B
est: 5.09B (-3.5%)
|
4.63B
est: 4.69B (-1.3%)
|
4.48B
est: 4.54B (-1.4%)
|
4.83B
est: 4.86B (-0.7%)
|
5.30B
est: 5.30B (-0.1%)
|
4.63B
est: 5.40B (-14.2%)
|
4.92B
est: 4.92B (+0.1%)
|
4.98B
est: 4.97B (+0.2%)
|
4.93B
est: 4.98B (-1.1%)
|
4.69B
est: 4.66B (+0.7%)
|
6.21B
est: 6.16B (+0.8%)
|
8.21B
est: 8.24B (-0.4%)
|
6.40B
est: 5.86B (+9.2%)
|
5.72B
est: 5.77B (-0.8%)
|
5.49B
est: 5.47B (+0.2%)
|
5.69B
5.47B – 5.88B
+3.9% YoY
|
5.87B
5.35B – 6.23B
+3.2% YoY
|
6.11B
6.10B – 6.12B
+4.1% YoY
|
6.09B
5.70B – 6.38B
-0.3% YoY
|
6.58B
6.16B – 6.90B
+8.1% YoY
|
| EBITDA |
1.08B
est: 1.19B (-9.2%)
|
809.00M
est: 973.20M (-16.9%)
|
638.20M
est: 694.64M (-8.1%)
|
998.00M
est: 604.10M (+65.2%)
|
1.06B
est: 1.04B (+2.5%)
|
904.10M
est: 980.87M (-7.8%)
|
914.10M
est: 862.62M (+6.0%)
|
755.20M
est: 1.52B (-50.4%)
|
-70.30M
est: 838.88M (-108.4%)
|
670.30M
est: 645.04M (+3.9%)
|
1.46B
est: 687.78M (+112.0%)
|
1.85B
est: 712.68M (+159.0%)
|
878.30M
est: 950.18M (-7.6%)
|
807.40M
est: 957.14M (-15.6%)
|
396.70M
est: 886.89M (-55.3%)
|
921.64M
886.12M – 952.18M
+3.9% YoY
|
951.08M
867.73M – 1.01B
+3.2% YoY
|
990.10M
989.04M – 991.17M
+4.1% YoY
|
986.79M
924.31M – 1.03B
-0.3% YoY
|
1.07B
999.13M – 1.12B
+8.1% YoY
|
| EBIT |
619.70M
est: 856.54M (-27.7%)
|
280.20M
est: 560.56M (-50.0%)
|
126.30M
est: 249.67M (-49.4%)
|
408.50M
est: 122.23M (+234.2%)
|
486.40M
est: 491.06M (-0.9%)
|
327.40M
est: 482.43M (-32.1%)
|
404.30M
est: 307.27M (+31.6%)
|
381.90M
est: 428.70M (-10.9%)
|
-625.20M
est: 390.61M (-260.1%)
|
266.80M
est: -490.13M (+154.4%)
|
1.14B
est: -522.61M (+317.3%)
|
1.67B
est: -541.53M (+407.9%)
|
459.60M
est: 535.51M (-14.2%)
|
334.50M
est: 539.43M (-38.0%)
|
-105.40M
est: 499.84M (-121.1%)
|
519.42M
499.40M – 536.63M
+3.9% YoY
|
536.01M
489.04M – 569.43M
+3.2% YoY
|
558.01M
557.41M – 558.61M
+4.1% YoY
|
556.14M
520.93M – 582.77M
-0.3% YoY
|
601.15M
563.09M – 629.94M
+8.1% YoY
|
| Net Income |
356.10M
est: 523.68M (-32.0%)
|
112.80M
est: 323.54M (-65.1%)
|
2.60M
est: 109.16M (-97.6%)
|
203.80M
est: 2.78M (+7,229.9%)
|
246.70M
est: 225.76M (+9.3%)
|
179.20M
est: 251.41M (-28.7%)
|
232.00M
est: 163.15M (+42.2%)
|
246.10M
est: 876.93M (-71.9%)
|
-642.60M
est: 246.74M (-360.4%)
|
189.20M
est: -587.28M (+132.2%)
|
806.90M
est: -626.20M (+228.9%)
|
1.25B
est: -648.87M (+292.8%)
|
313.60M
est: 124.40M (+152.1%)
|
241.00M
est: 135.70M (+77.6%)
|
-821.10M
est: -49.73M (-1,551.2%)
|
39.28M
-27.33M – 73.04M
+179.0% YoY
|
131.87M
11.62M – 190.70M
+235.7% YoY
|
198.83M
104.06M – 247.98M
+50.8% YoY
|
252.36M
231.59M – 268.07M
+26.9% YoY
|
326.14M
299.29M – 346.44M
+29.2% YoY
|
| SGA |
404.80M
est: 419.20M (-3.4%)
|
399.40M
est: 372.91M (+7.1%)
|
383.70M
est: 405.00M (-5.3%)
|
404.30M
est: 412.14M (-1.9%)
|
448.20M
est: 450.40M (-0.5%)
|
387.80M
est: 457.26M (-15.2%)
|
440.90M
est: 352.51M (+25.1%)
|
463.20M
est: 445.70M (+3.9%)
|
460.10M
est: 465.41M (-1.1%)
|
430.10M
est: 421.13M (+2.1%)
|
456.40M
est: 449.04M (+1.6%)
|
525.70M
est: 465.29M (+13.0%)
|
515.00M
est: 368.23M (+39.9%)
|
549.50M
est: 370.92M (+48.1%)
|
—
est: 343.70M (-100.0%)
|
357.17M
343.40M – 369.00M
+3.9% YoY
|
368.58M
336.28M – 391.55M
+3.2% YoY
|
383.70M
383.29M – 384.11M
+4.1% YoY
|
382.42M
358.20M – 400.72M
-0.3% YoY
|
413.37M
387.20M – 433.16M
+8.1% YoY
|
| EPS |
7.10
est: 9.29 (-23.6%)
|
2.43
est: 1.65 (+47.5%)
|
0.05
est: 0.24 (-77.8%)
|
4.10
est: 4.14 (-1.0%)
|
4.97
est: 3.99 (+24.6%)
|
3.38
est: 3.45 (-1.9%)
|
4.67
est: 4.83 (-3.4%)
|
4.95
est: 6.19 (-20.0%)
|
-12.94
est: 1.16 (-1,210.8%)
|
3.81
est: 3.68 (+3.6%)
|
16.24
est: 15.42 (+5.3%)
|
25.18
est: 24.92 (+1.0%)
|
6.31
est: 2.50 (+152.0%)
|
4.85
est: 4.39 (+10.4%)
|
-16.53
est: -1.00 (-1,551.3%)
|
0.61
-0.55 – 1.47
+161.4% YoY
|
2.30
0.23 – 3.84
+273.8% YoY
|
3.91
2.09 – 4.99
+70.3% YoY
|
5.08
4.66 – 5.40
+30.0% YoY
|
6.57
6.02 – 6.97
+29.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Amundi MDAX ESG UCITS ETF Dist C007.DE | 1.37% | 3.07M | 0.30% |
| 2 | Amundi MDAX ESG II UCITS ETF Dist E907.DE | 1.37% | 1.54M | 0.30% |
| 3 | Xtrackers MDAX ESG Screened UCITS ETF 1D XDGM.DE | 1.31% | 1.38M | 0.40% |
| 4 | iShares MDAX UCITS ETF (DE) EXS3.DE | 1.14% | 20.06M | 0.51% |
| 5 | iShares MDAX UCITS ETF (DE) EXID.DE | 1.14% | 457.4K | 0.51% |
| 6 | Invesco MDAX UCITS ETF DEAM.DE | 1.13% | 9.75M | 0.19% |
| 7 | Amundi MDAX UCITS ETF Dist MD4X.DE | 1.10% | 2.78M | 0.20% |
| 8 | Invesco Global Clean Energy UCITS ETF GCED.L | 0.91% | 1.26M | 0.60% |
| 9 | Invesco Global Clean Energy UCITS ETF GCLE.L | 0.91% | 1.26M | 0.60% |
| 10 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.32% | 2.35M | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Christian Hartel | Chief Executive Officer, President & Member of Executive Board | 1M | — |
| Christian Kirsten | Member of the Executive Board | 1M | — |
| Tobias Ohler | Chief Financial Officer & Member of the Executive Board | 1M | — |
| Angela Worl | Head of Human Resource, Personnel Director & Member of Executive Board | 823.9K | female |
| Joerg Krey | Senior Vice President of Corporate Engineering & CDO Operations | — | male |
| Martina Schulze-Adams | Senior Vice President of Corporate R&D and Head of Consortium | — | female |
| Mathias Wiedemann | President of Biosolutions division | — | — |
| Peter Summo | President of Polymers Business | — | male |
| Rainald Hagenhues | Head of Corproate Accounting & Tax | — | male |
| Joerg Hoffmann | Head of Investor Relations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for WCH.DE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
